Clinical Trials on Human Papillomavirus-Related Malignant Neoplasm

Total 17212 results

First Affiliated Hospital, Sun Yat-Sen University
Jingchu University of Technology

Unknown

A Safety and Efficacy Study of TALEN and CRISPR/Cas9 in the Treatment of HPV-related Cervical Intraepithelial NeoplasiaⅠ

Human Papillomavirus-Related Malignant Neoplasm

China
Huazhong University of Science and Technology

Unknown

Study of Molecular-targeted Therapy Using Zinc Finger Nuclease in Cervical Precancerous Lesions

Human Papillomavirus-Related Malignant Neoplasm

China
Huazhong University of Science and Technology

Recruiting

Study of Targeted Therapy Using Transcription Activator-like Effector Nucleases in Cervical Precancerous Lesions

Human Papillomavirus-Related Malignant Neoplasm

China
Ohio State University Comprehensive Cancer Center
National Cancer Institute (NCI)

Recruiting

I Vaccinate: Testing Multi-Level Interventions to Improve HPV Vaccination (IVaccinate)

Cervical Carcinoma | Human Papillomavirus-Related Malignant Neoplasm

United States
Suzhou Transcenta Therapeutics Co., Ltd.

Terminated

Study of TST005 in Patients With Locally Advanced or Metastatic Solid Tumors

Locally Advanced or Metastatic Cancers | Metastatic Human Papillomavirus-Related Malignant Neoplasm

United States
Pamela Munster
Novartis

Withdrawn

Alpelisib in Combination With Carboplatin in Patients With Solid Tumors and HPV-Positive Squamous Cell Carcinoma

Locally Advanced Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Solid Tumors, Adult | HPV-Related Squamous Cell Carcinoma | Human Papillomavirus-Related Carcinoma | PIK3CA Mutation-Related Tumors | PIK3CA Mutation | Human Papillomavirus-Related Squamous Cell Carcinoma

United States
National Cancer Institute (NCI)

Active, not recruiting

Extended Follow-up of Women Who Received One, Two, and Three Doses of the HPV Vaccine in the Costa Rica Vaccine Trial (CVT), ESCUDDO-CVT Study

Human Papillomavirus Infection | Human Papillomavirus-Related Malignant Neoplasm

Costa Rica
National Cancer Institute (NCI)

Not yet recruiting

Testing RG1-VLP Vaccine to Prevent HPV-related Cancers

Human Papillomavirus-Related Carcinoma

United States, Austria
Fred Hutchinson Cancer Center

Recruiting

Clinical Decision Support Tools to Increase Human Papillomavirus (HPV) Vaccination in Adolescents in Pharmacies

Human Papillomavirus-Related Carcinoma

United States
Ohio State University Comprehensive Cancer Center

Completed

Human Papillomavirus Education Programs

Human Papillomavirus-Related Carcinoma

United States
University of Michigan

Completed

MeFirst: A Tailored Intervention to HPV Vaccine Decision Making

Human Papillomavirus-Related Carcinoma

United States
National Cancer Institute (NCI)

Active, not recruiting

Recombinant Human Papillomavirus Nonavalent Vaccine in Preventing Human Papilloma Virus in Younger Healthy Participants

Human Papillomavirus-Related Carcinoma

United States
Memorial Sloan Kettering Cancer Center

Completed

Ribavirin for Patients With Recurrent/Metastatic (R/M) Human Papillomavirus (HPV)-Related Malignancies

Human Papillomavirus (HPV)-Related Malignancies | Recurrent/Metastatic (R/M) Human Papillomavirus (HPV)-Related Malignancies

United States
National Cancer Institute (NCI)

Active, not recruiting

Single Dose of Cervarix Vaccine in Girls or Three Doses of Gardasil Vaccine in Women for the Prevention of Human Papillomavirus Infection, the PRIMAVERA-ESCUDDO Trial

Human Papillomavirus-Related Cervical Carcinoma

Costa Rica
Gilead Sciences

Terminated

Study to Evaluate the Safety and Efficacy of KITE-439 in HLA-A*02:01+ Adults With Relapsed/Refractory HPV16+ Cancers

Human Papillomavirus (HPV) 16+ Relapsed/Refractory Cancer

United States
Baylor College of Medicine
The Methodist Hospital Research Institute; Center for Cell and Gene Therapy...

Active, not recruiting

HPV-16/18 E6/E7-Specific T Lymphocytes, Relapsed HPV-Associated Cancers, HESTIA (HESTIA)

Human Papillomavirus-Related Carcinoma | Human Papillomavirus Positive Oropharyngeal Carcinoma | Human Papillomavirus Positive Cervical Carcinoma | Human Papillomavirus Positive Anal Carcinoma | Human Papillomavirus Positive Vulvar Carcinoma | Human Papillomavirus Positive Penile Carcinoma

United States
University of Georgia

Completed

Human Papilloma Virus (HPV) Vaccination Among Rural African American Primary Caregivers and Daughters

Human Papillomavirus

United States
Kaiser Permanente
National Cancer Institute (NCI)

Recruiting

Provider Recommendation and HPV Vaccination (HPVV)

Human Papillomavirus

United States
Queen Mary University of London

Completed

Predictors of CIN Study Series 5.0:Stability Study in Vaginal Self-samples (Predictors50)

Human Papillomavirus
Lake Cumberland District Health Department
Merck Sharp & Dohme LLC

Completed

A Study to Compare the Impact of a School Based HPV Program on Vaccination Uptake and Completion Rates

Human Papillomavirus

United States
The University of Hong Kong
Queen Mary Hospital, Hong Kong

Unknown

Psychosocial Effect of HPV Positivity

Human Papillomavirus

China
Global Alliance to Immunize Against AIDS Vaccine...
Merck Sharp & Dohme LLC

Unknown

KAP/WTP and HPV Prevalence Studies in a Developing World Setting (Bamako, Mali) (HPV)

Human Papillomavirus

Mali
The Alfred
Merck Sharp & Dohme LLC

Completed

Human Papillomavirus in Young People Epidemiological Research 2 (HYPER2) (HYPER2)

Human Papillomavirus Infection | Human Papillomavirus

Australia
H. Lee Moffitt Cancer Center and Research Institute
Merck Sharp & Dohme LLC

Completed

Study of Gardasil in Mid-Adult Males (MAM)

Human Papillomavirus

United States, Mexico
Laval University

Completed

Immunogenicity of Gardasil and Twinrix and the Effect of a Dose of Gardasil or Cervarix Given 42 Months Later.

Human Papillomavirus

Canada
University Hospital, Toulouse

Completed

Detection of Human Papillomavirus in Polymerase Chain for Suspicious Lesions of the Amygdala: Concordance Smear-Biopsy (HPV-BIOFRO)

Human Papillomavirus

France
University of North Carolina, Chapel Hill
Harvard Medical School (HMS and HSDM); Pfizer; North Carolina Department of Health...

Completed

Making Effective Human Papillomavirus (HPV) Vaccine Recommendations

Human Papillomavirus

United States
University of Cincinnati

Recruiting

Let's K-Talk - HPV Study for Ethnic Koreans

Papillomavirus Vaccines | Human Papillomavirus Viruses

United States
Mayo Clinic
National Cancer Institute (NCI)

Recruiting

HPV Educational Intervention to Increase Acceptance and Completion of Free HPV Vaccination Among Underserved Adults

Human Papillomavirus Infection | Human Papillomavirus-Related Carcinoma

United States
University of Chicago
Stand Up To Cancer

Recruiting

Novel Outreach Methods to Increase Enrollment to Early Phase Clinical Trials

Cancer | Malignant Neoplasm | Malignancy

United States
Institut de Cancérologie de Lorraine

Completed

Agreement Between Oral and Cervical Human Papillomavirus Infection in a French Cohort (PAPILLOR)

Human Papillomavirus-Related Cervical Carcinoma

France
University of British Columbia
Merck Canada Inc.

Completed

Long Term Immune Memory Responses to HPV Vaccination Following 2 vs 3 Doses of Quad-HPV Vaccine (Merck08)

Human Papillomavirus

Canada
University of North Carolina, Chapel Hill
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Normalizing HPV Vaccination in Preteens With a Serious Video Game

Human Papillomavirus

United States
Northwestern University
National Cancer Institute (NCI); National Institutes of Health (NIH)

Completed

txt2protect: Using Text Messaging to Increase HPV Vaccination Among Young Sexual Minority Men (t2p)

Human Papillomavirus

United States
Merck Sharp & Dohme LLC

Completed

Immunogenicity and Tolerability of V503 Versus GARDASIL (V503-009)

Human Papillomavirus
Genexine, Inc.

Completed

Safety and Tolerability of GX-I7 in HPV-infected Female Volunteers

Human Papillomavirus

Korea, Republic of
Columbia University
Agency for Healthcare Research and Quality (AHRQ)

Completed

Interactive, Health Literacy Promoting Text Messages and HPV Vaccine Completion In Minority Adolescents

Human Papillomavirus

United States
Emory University

Completed

Tailoring of Vaccine-Focused Messages: Disease Salience

Human Papillomavirus

United States
University of Arkansas
National Cancer Institute (NCI)

Completed

A Phase I Clinical Trial of an HPV Therapeutic Vaccine

Human Papillomavirus

United States
National Cancer Institute (NCI)
Bill and Melinda Gates Foundation

Enrolling by invitation

Comparing One or Two Doses of the Human Papillomavirus Vaccine for the Prevention of Human Papillomavirus Infection, ESCUDDO Study (ESCUDDO)

Human Papillomavirus Infection | Human Papillomavirus-Related Cervical Carcinoma

Costa Rica
Columbia University
National Cancer Institute (NCI); Makerere University

Not yet recruiting

HPV Vaccine Reminders - SEARCH II Study

Human Papillomavirus Vaccination

United States, Uganda
Washington University School of Medicine
National Cancer Institute (NCI)

Active, not recruiting

Increasing Optimal Use of HPV Vaccination in Primary Care

Human Papillomavirus Vaccines

United States
Arizona State University
National Institute on Minority Health and Health Disparities (NIMHD); Adelante...

Completed

Community Pharmacists Vaccinate Against Cancer (CPVAC)

Human Papillomavirus Vaccines

United States
University of Texas Southwestern Medical Center
National Cancer Institute (NCI); Southern Methodist University; Parkland Health...

Terminated

Developing a Self-persuasion Intervention Promoting Adolescent HPV Vaccination: Feasibility Trial

Human Papillomavirus Vaccines

United States
Indiana University
Merck Sharp & Dohme LLC

Completed

County Level Correlates of HPV Vaccine Series Completion Among Children Ages 11-14 Years in Indiana

Human Papillomavirus Vaccination

United States
Laval University
Centers for Disease Control and Prevention

Completed

Immunogenicity of One Dose of Gardasil and One Dose of Gardasil-9

Human Papillomavirus Vaccines

Canada
Xiamen Innovax Biotech Co., Ltd

Completed

Immunogenicity and Safety of One Dose of HPV Vaccine

Human Papillomavirus Vaccines

China
Plan A Health, Inc
Merck Sharp & Dohme LLC

Enrolling by invitation

Investigating HPV Vaccination Uptake in Adults Aged 18-35 Seeking Care at a Health Clinic in Rural Mississippi

Human Papillomavirus Vaccination

United States
London School of Hygiene and Tropical Medicine
Merck Sharp & Dohme LLC; Public Health England; University of Cambridge

Active, not recruiting

HPV Vaccination in Africa- New Delivery Schedules Alias The HANDS HPV Vaccine Trial (HPV)

Human Papillomavirus Vaccine

Gambia
The University of Texas Health Science Center,...
Baylor College of Medicine; Cancer Prevention Research Institute of Texas

Completed

Multi-component Interventions to Increase HPV Vaccination in a Network of Pediatric Clinics

Human Papillomavirus (HPV)

United States

Clinical Trials on Human Papillomavirus-Related Malignant Neoplasm

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Czech Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations